Transgender Activist Women’s March Leader Indicted for

New Post Public Reply Private Reply Replies (0) Message Board
Lmcat
712
Transgender Activist Women’s March Leader Indicted for Theft
May 10, 2019

Not all Women’s March leaders are anti-Semites, some are just plain ordinary thieves. Rebekah Katherine Brewis was one of the founders of a Women’s March protest against President Donald Trump.

222e553ca287cb503656bed25427317a.png

Brewis, who is transgender and an activist has been charged with three counts of theft and two counts of felony computer crime.

Brewis, who self identifies as a law-abiding citizen claims that the charges are false. Brewis struck a deal with the Women’s March take the donations through her group, which was supposed to be a tax-exempt organization and then would turn over the money from tee shirt sales and donations to the Women’s March.

She never did and now they want their money.


From The Blaze

Brewis lead an organization named PDX Trans Pride that had a fiscal relationship with the Women’s March so that they could receive tax-free donations. Later, she was accused of stealing money that had been gathered from t-shirt sales and other donations.

However, an investigation from the Oregonian concluded that PDX Trans Pride was not registered as a charity to accept tax-free donations.

A jury indicted her on three charges of first degree aggravated theft and two charges of felony computer crime.


Brewis has denied the allegations, saying simply, “The allegations are absolutely unfounded.”

The PDX Trans Pride official Twitter account has made their account private.

She had previously been convicted of robbery in 2000 and sentenced to 70 months in prison, according to the Oregonian. She was known as Jorey Brewis at that time.

https://steadfastandloyal.com/news-for-you/tr...for-theft/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

USDA Under Scrutiny as ASPCA Reports on Puppy Mill Violations

Updated Category News Views 322

ASPCA's Shocking Report on Puppy Mill Violations In a recent analysis by the ASPCA, alarming statistics have surfaced regarding animal welfare violations at USDA-licensed commercial dog breeding facilities. The findings reveal that in a given year, substantial breaches of care standards were documented, yet no actions were taken to ensure the safety of the animals....

Continue Reading
PowerReviews Unveils Partner Program to Amplify UGC Value

Updated Category News Views 1653

PowerReviews Launches Comprehensive Partner Program PowerReviews, a reputable name backed by 1WorldSync, has initiated an exciting Partner Program aimed at revolutionizing the way user-generated content (UGC) is leveraged. This initiative is designed to not only boost productivity but also facilitate enhanced revenue opportunities for partners who promote its advanced...

Continue Reading
Turnspire Capital Partners Expands Portfolio with GHP Group

Updated Category News Views 81

Turnspire Capital Partners pulled the trigger on acquiring GHP Group back in 2024, a move that sent shockwaves through the consumer product landscape. This was no random buy; GHP's got its fingers in the pie of outdoor living products—think patio heaters and grills—all under reputable brands like Dyna-Glo and Pleasant Hearth. GHP Group: A Heavyweight Player in Outdoor...

Continue Reading
MPI Corporation Launches Groundbreaking 250 GHz Probe System

Updated Category News Views 187

Enhancing Precision in Semiconductor Testing In the fast-evolving world of semiconductor technology, precision and performance are critical. MPI Corporation has once again demonstrated its innovative spirit by unveiling a revolutionary 250 GHz broadband test solution. This state-of-the-art system combines the power of the TITAN™ Probes and MPI's extensive expertise in...

Continue Reading
Passage Bio's Gene Therapy Strategy: Hope for Dementia Treatments

Updated Category News Views 76

Promising Advances in Gene Therapy Recently, Passage Bio, Inc. (NASDAQ: PASG), a pioneering company in genetic medicine, showcased groundbreaking preclinical and interim clinical results for its gene therapy product, PBFT02. This was presented at a major congress focused on gene and cell therapy. Designed specifically to target frontotemporal dementia associated with GRN...

Continue Reading